Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus

INTRODUCTION: Type 2 diabetes is a risk factor for dementia and Parkinson’s disease (PD). Drug treatments for diabetes, such as metformin, could be used as novel treatments for these neurological conditions. Using electronic health records from the USA (OPTUM EHR) we aimed to assess the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Newby, Danielle, Linden, Andrew Brent, Fernandes, Marco, Molero, Yasmina, Winchester, Laura, Sproviero, William, Ghose, Upamanyu, Li, Qingqin S, Launer, Lenore J, van Duijn, Cornelia M, Nevado-Holgado, Alejo J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478804/
https://www.ncbi.nlm.nih.gov/pubmed/36109050
http://dx.doi.org/10.1136/bmjdrc-2022-003036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478804/
https://www.ncbi.nlm.nih.gov/pubmed/36109050
http://dx.doi.org/10.1136/bmjdrc-2022-003036

Ejemplares similares